share_log

Merck & Co | POSASR: Post-effective amendment to an automatic shelf registration statement on Form S-3ASR or Form F-3ASR

Merck & Co | POSASR: Post-effective amendment to an automatic shelf registration statement on Form S-3ASR or Form F-3ASR

默沙東 | POSASR：註冊聲明修正稿
美股sec公告 ·  05/15 23:35
牛牛AI助理已提取核心訊息
Merck & Co., Inc. (Merck), known as MSD outside the United States and Canada, has filed a post-effective amendment to a registration statement with the U.S. Securities and Exchange Commission (SEC) on May 14, 2024. The amendment pertains to the registration of debt securities by both Merck and its wholly-owned subsidiary, MSD Netherlands Capital B.V. (MSD Netherlands). The registration statement includes an indenture between Merck and U.S. Bank Trust National Association, serving as trustee, and a similar indenture between MSD Netherlands, Merck, and the trustee. These documents govern the issuance of the debt securities, which are unsecured and may be offered in various transactions at fixed or variable prices. The securities may be sold through underwriters, dealers, agents, or directly to investors. Merck's filing ensures compliance with federal securities laws and provides legal frameworks for potential future debt offerings by both Merck and MSD Netherlands.
Merck & Co., Inc. (Merck), known as MSD outside the United States and Canada, has filed a post-effective amendment to a registration statement with the U.S. Securities and Exchange Commission (SEC) on May 14, 2024. The amendment pertains to the registration of debt securities by both Merck and its wholly-owned subsidiary, MSD Netherlands Capital B.V. (MSD Netherlands). The registration statement includes an indenture between Merck and U.S. Bank Trust National Association, serving as trustee, and a similar indenture between MSD Netherlands, Merck, and the trustee. These documents govern the issuance of the debt securities, which are unsecured and may be offered in various transactions at fixed or variable prices. The securities may be sold through underwriters, dealers, agents, or directly to investors. Merck's filing ensures compliance with federal securities laws and provides legal frameworks for potential future debt offerings by both Merck and MSD Netherlands.
默沙東公司（Merck）（在美國和加拿大以外被稱爲默沙東）已於2024年5月14日向美國證券交易委員會（SEC）提交了註冊聲明的生效後修訂。該修訂涉及默沙東及其全資子公司默沙東荷蘭資本有限公司（MSD 荷蘭）的債務證券註冊。註冊聲明包括默沙東與作爲受託人的美國銀行信託全國協會之間的契約，以及默沙東荷蘭、默沙東和受託人之間的類似契約。這些文件管理債務證券的發行，債務證券是無抵押的，可以在各種交易中以固定或可變價格發行。證券可以通過承銷商、交易商、代理人出售，也可以直接出售給投資者。默沙東的文件確保遵守聯邦證券法，併爲默沙東和荷蘭默沙東未來可能的債務發行提供法律框架。
默沙東公司（Merck）（在美國和加拿大以外被稱爲默沙東）已於2024年5月14日向美國證券交易委員會（SEC）提交了註冊聲明的生效後修訂。該修訂涉及默沙東及其全資子公司默沙東荷蘭資本有限公司（MSD 荷蘭）的債務證券註冊。註冊聲明包括默沙東與作爲受託人的美國銀行信託全國協會之間的契約，以及默沙東荷蘭、默沙東和受託人之間的類似契約。這些文件管理債務證券的發行，債務證券是無抵押的，可以在各種交易中以固定或可變價格發行。證券可以通過承銷商、交易商、代理人出售，也可以直接出售給投資者。默沙東的文件確保遵守聯邦證券法，併爲默沙東和荷蘭默沙東未來可能的債務發行提供法律框架。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

獨立文件3  查看翻譯

獨立文件4  查看翻譯

獨立文件5  查看翻譯

獨立文件6  查看翻譯

獨立文件7  查看翻譯

獨立文件8  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。